Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Mar 2023
The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.
Read Full NewsNew York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.
The drug was previously approved for stage 2 T1D.
Findings suggest young females should be assessed and, if at risk, monitored.
Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.
Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.
The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.
Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.
1.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
2.
Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL
3.
Researchers publish action plan to address appendiceal cancer enigmas
4.
Shorter but More Intense RT: A Better Option for HNSCC?
5.
A healthier lifestyle after bowel screening shown to prevent bowel cancer
1.
Breaking Down the Benefits and Risks of Hematopoietic Stem Cell Transplantation
2.
The Role of Calcium Corrections in Accurate Blood Test Results
3.
Breaking Down the Different Types of Lymphoma: What You Need to Know
4.
Targeting Iron Recycling Pathways in Hematologic Disease
5.
Exploring the Role of Fecal Leukocytes in Intestinal Health
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
3.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
4.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge